• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

射血分数保留的心力衰竭住院患者的心率与预后

Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction.

作者信息

Lam Phillip H, Dooley Daniel J, Deedwania Prakash, Singh Steven N, Bhatt Deepak L, Morgan Charity J, Butler Javed, Mohammed Selma F, Wu Wen-Chih, Panjrath Gurusher, Zile Michael R, White Michel, Arundel Cherinne, Love Thomas E, Blackman Marc R, Allman Richard M, Aronow Wilbert S, Anker Stefan D, Fonarow Gregg C, Ahmed Ali

机构信息

Center for Health and Aging, Veterans Affairs Medical Center, Washington, DC; Department of Medicine, Georgetown University, Washington, DC; Division of Cardiology, MedStar Washington Hospital Center, Washington, DC.

Center for Health and Aging, Veterans Affairs Medical Center, Washington, DC; Division of Cardiology, Department of Medicine, University of California, San Francisco, Fresno, California.

出版信息

J Am Coll Cardiol. 2017 Oct 10;70(15):1861-1871. doi: 10.1016/j.jacc.2017.08.022.

DOI:10.1016/j.jacc.2017.08.022
PMID:28982499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8801201/
Abstract

BACKGROUND

A lower heart rate is associated with better outcomes in patients with heart failure (HF) with reduced ejection fraction (EF). Less is known about this association in patients with HF with preserved ejection fraction (HFpEF).

OBJECTIVES

The aims of this study were to examine associations of discharge heart rate with outcomes in hospitalized patients with HFpEF.

METHODS

Of the 8,873 hospitalized patients with HFpEF (EF ≥50%) in the Medicare-linked OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) registry, 6,286 had a stable heart rate, defined as ≤20 beats/min variation between admission and discharge. Of these, 2,369 (38%) had a discharge heart rate of <70 beats/min. Propensity scores for discharge heart rate <70 beats/min, estimated for each of the 6,286 patients, were used to assemble a cohort of 2,031 pairs of patients with heart rate <70 versus ≥70 beats/min, balanced on 58 baseline characteristics.

RESULTS

The 4,062 matched patients had a mean age of 79 ± 10 years, 66% were women, and 10% were African American. During 6 years (median 2.8 years) of follow-up, all-cause mortality was 65% versus 70% for matched patients with a discharge heart rate <70 versus ≥70 beats/min, respectively (hazard ratio [HR]: 0.86; 95% confidence interval [CI]: 0.80 to 0.93; p < 0.001). A heart rate <70 beats/min was also associated with a lower risk for the combined endpoint of HF readmission or all-cause mortality (HR: 0.90; 95% CI: 0.84 to 0.96; p = 0.002), but not with HF readmission (HR: 0.93; 95% CI: 0.85 to 1.01) or all-cause readmission (HR: 1.01; 95% CI: 0.95 to 1.08). Similar associations were observed regardless of heart rhythm or receipt of beta-blockers.

CONCLUSIONS

Among hospitalized patients with HFpEF, a lower discharge heart rate was independently associated with a lower risk of all-cause mortality, but not readmission.

摘要

背景

射血分数降低的心力衰竭(HF)患者心率较低与较好的预后相关。而对于射血分数保留的心力衰竭(HFpEF)患者,这种关联的了解较少。

目的

本研究旨在探讨住院HFpEF患者出院时心率与预后的关联。

方法

在与医疗保险相关的OPTIMIZE-HF(住院心力衰竭患者启动挽救生命治疗的组织项目)登记处的8873例住院HFpEF患者(射血分数[EF]≥50%)中,6286例患者心率稳定,定义为入院和出院时心率变化≤20次/分钟。其中,2369例(38%)出院时心率<70次/分钟。对6286例患者中的每一例,估算出院时心率<70次/分钟的倾向评分,用于组建一个队列,其中2031对患者心率<70次/分钟与≥70次/分钟,在58项基线特征上达到平衡。

结果

4062例匹配患者的平均年龄为79±10岁,66%为女性,10%为非裔美国人。在6年(中位时间2.8年)的随访中,出院时心率<70次/分钟与≥70次/分钟的匹配患者的全因死亡率分别为65%和70%(风险比[HR]:0.86;95%置信区间[CI]:0.80至0.93;P<0.001)。心率<70次/分钟还与HF再入院或全因死亡率的联合终点风险较低相关(HR:0.90;95%CI:0.84至0.96;P=0.002),但与HF再入院(HR:0.93;95%CI:0.85至1.01)或全因再入院(HR:1.01;95%CI:0.95至1.08)无关。无论心律或是否接受β受体阻滞剂治疗,均观察到类似的关联。

结论

在住院HFpEF患者中,较低的出院心率与较低的全因死亡率风险独立相关,但与再入院无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6059/8801201/39b45a9c3c2b/nihms-903962-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6059/8801201/ee22d297f425/nihms-903962-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6059/8801201/8094dfa09486/nihms-903962-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6059/8801201/bf72d7510b64/nihms-903962-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6059/8801201/7507bd8a2ecc/nihms-903962-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6059/8801201/39b45a9c3c2b/nihms-903962-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6059/8801201/ee22d297f425/nihms-903962-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6059/8801201/8094dfa09486/nihms-903962-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6059/8801201/bf72d7510b64/nihms-903962-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6059/8801201/7507bd8a2ecc/nihms-903962-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6059/8801201/39b45a9c3c2b/nihms-903962-f0005.jpg

相似文献

1
Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction.射血分数保留的心力衰竭住院患者的心率与预后
J Am Coll Cardiol. 2017 Oct 10;70(15):1861-1871. doi: 10.1016/j.jacc.2017.08.022.
2
Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.地高辛在射血分数保留的心力衰竭患者中的起始应用和结局。
Am J Med. 2020 Oct;133(10):1187-1194. doi: 10.1016/j.amjmed.2020.02.040. Epub 2020 Apr 6.
3
Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction.收缩压与射血分数保留的心力衰竭患者的结局。
JAMA Cardiol. 2018 Apr 1;3(4):288-297. doi: 10.1001/jamacardio.2017.5365.
4
Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.地高辛停药与射血分数降低的心力衰竭患者结局的关系。
J Am Coll Cardiol. 2019 Aug 6;74(5):617-627. doi: 10.1016/j.jacc.2019.05.064.
5
Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate.大剂量β受体阻滞剂在射血分数保留的心力衰竭伴心率增快患者中的作用。
Am J Med. 2018 Dec;131(12):1473-1481. doi: 10.1016/j.amjmed.2018.07.008. Epub 2018 Aug 1.
6
Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure.β受体阻滞剂的使用与收缩性心力衰竭医疗保险受益人的30天全因再入院情况
Am J Med. 2015 Jul;128(7):715-21. doi: 10.1016/j.amjmed.2014.11.036. Epub 2014 Dec 30.
7
Prior Heart Failure Hospitalization and Outcomes in Patients with Heart Failure with Preserved and Reduced Ejection Fraction.心力衰竭伴射血分数保留和降低患者的心力衰竭住院前情况和结局。
Am J Med. 2020 Jan;133(1):84-94. doi: 10.1016/j.amjmed.2019.06.040. Epub 2019 Jul 20.
8
Impact of heart rate changes during hospitalization on outcome in heart failure with preserved ejection fraction.住院期间心率变化对射血分数保留的心力衰竭患者预后的影响。
ESC Heart Fail. 2024 Oct;11(5):2901-2912. doi: 10.1002/ehf2.14721. Epub 2024 Mar 21.
9
Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.收缩压与射血分数降低的心力衰竭患者的结局。
J Am Coll Cardiol. 2019 Jun 25;73(24):3054-3063. doi: 10.1016/j.jacc.2019.04.022.
10
Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.医疗保险人群中心力衰竭伴射血分数保留、中间值和降低患者的结局。
Am Heart J. 2014 Nov;168(5):721-30. doi: 10.1016/j.ahj.2014.07.008. Epub 2014 Jul 22.

引用本文的文献

1
Artificial intelligence approaches for phenotyping heart failure in U.S. Veterans Health Administration electronic health record.美国退伍军人事务部电子健康记录中基于人工智能的心力衰竭表型分析方法。
ESC Heart Fail. 2024 Oct;11(5):3155-3166. doi: 10.1002/ehf2.14787. Epub 2024 Jun 14.
2
Impact of heart rate changes during hospitalization on outcome in heart failure with preserved ejection fraction.住院期间心率变化对射血分数保留的心力衰竭患者预后的影响。
ESC Heart Fail. 2024 Oct;11(5):2901-2912. doi: 10.1002/ehf2.14721. Epub 2024 Mar 21.
3
Upper extremity weakness: A novel risk factor for non-cardiovascular mortality among community-dwelling older adults.

本文引用的文献

1
Digoxin and 30-Day All-Cause Readmission in Long-Term Care Residents Hospitalized for Heart Failure.地高辛与心力衰竭长期住院患者 30 天全因再入院
J Am Med Dir Assoc. 2017 Sep 1;18(9):761-765. doi: 10.1016/j.jamda.2017.03.016. Epub 2017 May 11.
2
Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial.依伐布雷定治疗射血分数保留的心力衰竭患者的效果:EDIFY 随机安慰剂对照试验。
Eur J Heart Fail. 2017 Nov;19(11):1495-1503. doi: 10.1002/ejhf.876. Epub 2017 Apr 30.
3
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.
上肢无力:社区居住的老年人群中非心血管死亡率的新危险因素。
Arch Gerontol Geriatr. 2023 Sep;112:105021. doi: 10.1016/j.archger.2023.105021. Epub 2023 Apr 6.
4
Depressive symptoms, cognitive impairment, and all-cause mortality among REGARDS participants with heart failure.REGARDS研究中患有心力衰竭的参与者的抑郁症状、认知障碍和全因死亡率。
Eur Heart J Open. 2022 Oct 3;2(5):oeac064. doi: 10.1093/ehjopen/oeac064. eCollection 2022 Sep.
5
Length of stay and readmission in older adults hospitalized for heart failure.因心力衰竭住院的老年人的住院时间和再入院情况。
Arch Med Sci. 2020 Jan 8;17(4):891-899. doi: 10.5114/aoms.2019.89702. eCollection 2021.
6
Beta-blocker treatment in heart failure patients with atrial fibrillation: challenges and perspectives.心力衰竭合并心房颤动患者的β受体阻滞剂治疗:挑战与展望。
J Geriatr Cardiol. 2021 May 28;18(5):362-375. doi: 10.11909/j.issn.1671-5411.2021.05.008.
7
The corrected left ventricular ejection fraction: a potential new measure of ventricular function.校正后的左心室射血分数:一种潜在的心室功能新指标。
Int J Cardiovasc Imaging. 2021 Jun;37(6):1987-1997. doi: 10.1007/s10554-021-02193-4. Epub 2021 Feb 22.
8
Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation.β受体阻滞剂在急性心力衰竭伴心房颤动患者出院时的应用。
J Korean Med Sci. 2020 Aug 24;35(33):e278. doi: 10.3346/jkms.2020.35.e278.
9
Loop Diuretic Prescription and 30-Day Outcomes in Older Patients With Heart Failure.噻嗪类利尿剂处方与老年心力衰竭患者 30 天结局
J Am Coll Cardiol. 2020 Aug 11;76(6):669-679. doi: 10.1016/j.jacc.2020.06.022.
10
Heart failure with preserved ejection fraction: insights from recent clinical researches.射血分数保留的心力衰竭:来自近期临床研究的新视角。
Korean J Intern Med. 2020 May;35(3):514-534. doi: 10.3904/kjim.2020.104. Epub 2020 Apr 29.
《2017年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2017 Mar 7;135(10):e146-e603. doi: 10.1161/CIR.0000000000000485. Epub 2017 Jan 25.
4
Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure.肾素-血管紧张素系统抑制与降低医疗保险受益人心力衰竭患者30天全因再入院率
Am J Med. 2016 Oct;129(10):1067-73. doi: 10.1016/j.amjmed.2016.05.008. Epub 2016 Jun 2.
5
Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial.HFpEF 与 HFrEF 中β受体阻滞剂滴定的耐受性和可行性:来自 CIBIS-ELD 试验的见解。
JACC Heart Fail. 2016 Feb;4(2):140-149. doi: 10.1016/j.jchf.2015.10.008. Epub 2015 Dec 9.
6
Effect of Selective Heart Rate Slowing in Heart Failure With Preserved Ejection Fraction.射血分数保留的心力衰竭中选择性心率减慢的作用
Circulation. 2015 Nov 3;132(18):1719-25. doi: 10.1161/CIRCULATIONAHA.115.017119. Epub 2015 Sep 2.
7
Heart rate at hospital discharge in patients with heart failure is associated with mortality and rehospitalization.心力衰竭患者出院时的心率与死亡率和再次住院相关。
J Am Heart Assoc. 2015 Apr 22;4(4):e001626. doi: 10.1161/JAHA.114.001626.
8
Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure.β受体阻滞剂的使用与收缩性心力衰竭医疗保险受益人的30天全因再入院情况
Am J Med. 2015 Jul;128(7):715-21. doi: 10.1016/j.amjmed.2014.11.036. Epub 2014 Dec 30.
9
Calcium channel blockers and outcomes in older patients with heart failure and preserved ejection fraction.钙通道阻滞剂与老年射血分数保留的心力衰竭患者的预后
Circ Heart Fail. 2014 Nov;7(6):945-52. doi: 10.1161/CIRCHEARTFAILURE.114.001301. Epub 2014 Oct 8.
10
Beta-blockers in older patients with heart failure and preserved ejection fraction: class, dosage, and outcomes.老年射血分数保留的心力衰竭患者使用β受体阻滞剂:类别、剂量及预后
Int J Cardiol. 2014 May 15;173(3):393-401. doi: 10.1016/j.ijcard.2014.03.005. Epub 2014 Mar 11.